Log In
Print
BCIQ
Print
Print this Print this
 

navitoclax (ABT-263) (formerly RG7433)

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionPan inhibitor of BCL2 family proteins
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2) ; Bcl-XL
Mechanism of ActionBcl-2 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today